AbbVie Stock Drops 1.7% - What's Next?

Analysts weigh in on the pharmaceutical company's latest stock performance and outlook.

Published on Mar. 5, 2026

Got story updates? Submit your updates here. ›

AbbVie Inc. (NYSE:ABBV) saw its stock price fall 1.7% on Thursday, trading as low as $228.00. The company's shares closed at $232.07, with trading volume up 29% from the average session. Analysts have provided mixed ratings and price targets for AbbVie, with some maintaining a 'hold' rating and others raising their price targets.

Why it matters

AbbVie is a major pharmaceutical company with a diverse portfolio of drugs, so its stock performance and outlook are closely watched by investors. The company's ability to maintain growth and profitability is crucial, as it faces competition and potential patent expirations for some of its key products.

The details

Several brokerages have recently commented on AbbVie's stock. Weiss Ratings maintained a 'hold (c)' rating, while UBS Group cut its price target from $240 to $230 and Citigroup decreased its price objective from $235 to $230. On the other hand, Piper Sandler lifted its target price from $289 to $299 and gave the stock an 'overweight' rating.

  • AbbVie's stock price fell 1.7% on Thursday, March 5, 2026.

The players

AbbVie Inc.

A global, research-driven biopharmaceutical company that focuses on discovering, developing, and commercializing therapies for complex and often chronic medical conditions.

Weiss Ratings

A financial research and ratings company that provides independent ratings and analysis of stocks, mutual funds, and other financial products.

UBS Group

A global financial services firm that provides wealth management, asset management, and investment banking services.

Citigroup

A multinational investment bank and financial services corporation that provides a wide range of products and services, including banking, credit cards, and investment banking.

Piper Sandler

A leading investment bank and institutional securities firm that provides a full suite of investment banking and institutional securities services.

Got photos? Submit your photos here. ›

What they’re saying

“We must not let individuals continue to damage private property in San Francisco.”

— Robert Jenkins, San Francisco resident (San Francisco Chronicle)

“Fifty years is such an accomplishment in San Francisco, especially with the way the city has changed over the years.”

— Gordon Edgar, grocery employee (Instagram)

What’s next

The judge in the case will decide on Tuesday whether or not to allow Walker Reed Quinn out on bail.

The takeaway

This case highlights growing concerns in the community about repeat offenders released on bail, raising questions about bail reform, public safety on SF streets, and if any special laws to govern autonomous vehicles in residential and commercial areas.